These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 8630427

  • 1. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
    Delage R, Soiffer RJ, Dear K, Ritz J.
    Blood; 1991 Nov 15; 78(10):2759-67. PubMed ID: 1824268
    [Abstract] [Full Text] [Related]

  • 3. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
    Otazú IB, Tavares Rde C, Hassan R, Zalcberg I, Tabak DG, Seuánez HN.
    Leuk Res; 2002 Feb 15; 26(2):129-41. PubMed ID: 11755463
    [Abstract] [Full Text] [Related]

  • 4. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.
    Radich JP, Gehly G, Gooley T, Bryant E, Clift RA, Collins S, Edmands S, Kirk J, Lee A, Kessler P.
    Blood; 1995 May 01; 85(9):2632-8. PubMed ID: 7727789
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
    Lin F, van Rhee F, Goldman JM, Cross NC.
    Blood; 1996 May 15; 87(10):4473-8. PubMed ID: 8639810
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D.
    Blood; 1992 Jan 01; 79(1):276-82. PubMed ID: 1728316
    [Abstract] [Full Text] [Related]

  • 7. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr 01; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 8. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR.
    Thijsen SF, Schuurhuis GJ, van Oostveen JW, Theijsmeijer AP, Langenhuijsen MM, Ossenkoppele GJ.
    Leukemia; 1997 Feb 01; 11(2):301-5. PubMed ID: 9009097
    [Abstract] [Full Text] [Related]

  • 9. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
    van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC.
    Blood; 1996 Jun 15; 87(12):5213-7. PubMed ID: 8652835
    [Abstract] [Full Text] [Related]

  • 10. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
    Koren-Michowitz M, Shimoni A, Daraio F, Crasto F, Lorenzatti R, Volchek Y, Amariglio N, Gottardi E, Saglio G, Nagler A.
    Biol Blood Marrow Transplant; 2015 Oct 15; 21(10):1852-5. PubMed ID: 26151304
    [Abstract] [Full Text] [Related]

  • 11. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A.
    Blood; 2000 Apr 15; 95(8):2659-65. PubMed ID: 10753848
    [Abstract] [Full Text] [Related]

  • 12. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Sep 15; 17(9):1687-94. PubMed ID: 12970765
    [Abstract] [Full Text] [Related]

  • 13. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
    Okamoto R, Harano H, Matsuzaki M, Motomura S, Maruta A, Kodama F, Mohri H, Okubo T.
    Am J Clin Pathol; 1995 Nov 15; 104(5):510-6. PubMed ID: 7572810
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
    Wells SJ, Phillips CN, Winton EF, Farhi DC.
    Am J Clin Pathol; 1996 Jun 15; 105(6):756-60. PubMed ID: 8659451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Alyea EP, Soiffer RJ, Roy DC, Ritz J.
    Blood; 1994 Oct 01; 84(7):2109-14. PubMed ID: 7919323
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.